T
Tim Eden
Researcher at University of Manchester
Publications - 71
Citations - 2798
Tim Eden is an academic researcher from University of Manchester. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 29, co-authored 71 publications receiving 2537 citations. Previous affiliations of Tim Eden include Manchester Academic Health Science Centre.
Papers
More filters
Journal ArticleDOI
Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study
Raul C. Ribeiro,Raul C. Ribeiro,Eva Steliarova-Foucher,Ian Magrath,Jean Lemerle,Tim Eden,Caty Forget,Isabel Mortara,Isabelle Tabah-Fisch,Jose Julio Divino,Thomas Miklavec,Scott C. Howard,Scott C. Howard,Franco Cavalli +13 more
TL;DR: Assessment of baseline status of paediatric cancer care in ten countries receiving support and postulated 5-year survival showed that alliances between public, private, and international agencies might rapidly improve the outcome of children with cancer in these countries.
Journal ArticleDOI
The problem of treatment abandonment in children from developing countries with cancer.
TL;DR: There is an inequality gap between the outcome of childhood cancer in resource, rich and limited countries and abandonment of treatment is one of the reasons for this.
Journal ArticleDOI
Aetiology of childhood leukaemia
TL;DR: It appears increasingly likely that delayed, dysregulated responses to 'common' infectious agents play a major part in the conversion of pre-leukaemic clones into overt precursor B cell ALL, the most common form of childhood leukaemia.
Journal ArticleDOI
Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)
Anthony V. Moorman,Susan M. Richards,Hazel M. Robinson,Jonathan C. Strefford,Brenda Gibson,Sally E. Kinsey,Tim Eden,Ajay Vora,Chris Mitchell,Christine J. Harrison +9 more
TL;DR: Patients with acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21 (iAMP21) comprise a novel and distinct biological subgroup and have a significantly inferior event-free and overall survival at 5 years compared with other patients.
Journal ArticleDOI
Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study
TL;DR: The hypothesis that reduced exposure to infection in the first few months of life increases the risk of developing acute lymphoblastic leukaemia is supported.